Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells
2009; Springer Nature; Volume: 45; Issue: 2 Linguagem: Inglês
10.1038/bmt.2009.155
ISSN1476-5365
AutoresMichael Lioznov, Jean El Cheikh, Franz Albert Hoffmann, York Hildebrandt, Francis Ayuk, Christine Wolschke, Djordje Atanackovic, Georgia Schilling, Anita Badbaran, Ulrike Bacher, Boris Fehse, A Zander, Didier Blaise, Mohamad Mohty, Nicolaus Kröger,
Tópico(s)Hematopoietic Stem Cell Transplantation
Referência(s)